SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-181528
Filing Date
2022-06-24
Accepted
2022-06-24 16:20:04
Documents
12
Period of Report
2022-06-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d516441d8k.htm   iXBRL 8-K 27539
  Complete submission text file 0001193125-22-181528.txt   160060

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cgem-20220622.xsd EX-101.SCH 2885
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20220622_lab.xml EX-101.LAB 20213
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20220622_pre.xml EX-101.PRE 12610
6 EXTRACTED XBRL INSTANCE DOCUMENT d516441d8k_htm.xml XML 3717
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 221040369
SIC: 2836 Biological Products, (No Diagnostic Substances)